Xcout IntelSign inSubscribe

Surf Bio, Inc.

BiotechnologyPalo Alto, CA, United States

Surf Bio, Inc. is a biotechnology company that collaborates with multinational pharmaceutical firms on drug delivery technologies and therapeutic pipelines.

Subscribe to see Surf Bio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Surf Bio, Inc. at a glance

Surf Bio, Inc. is a biotechnology company headquartered in Palo Alto, United States. Its most recent funding round raised $16M in March 2022. Xcout tracks 2 named people at Surf Bio, Inc., including Bryan Mazlish (Chief Executive Officer).

As of 16 November 2026. Source: Xcout Intel.

Industry
Biotechnology
Headquarters
Palo Alto, CA, United States

Surf Bio, Inc. leadership

  • Bryan MazlishChief Executive Officer
  • Jennifer SchneiderPresident & Chief Medical Officer

Surf Bio, Inc. funding rounds

Every round on record:

DateRoundAmountInvestors
SEC Form D filing$16M—

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Surf Bio, Inc. competitors

A few of Surf Bio, Inc.'s closest competitors — see the full list of competitors and alternatives →

Sutro Biopharma, Inc.STRO · BiotechSouth San Francisco, CA, United States
68% matchPublic

Sutro Biopharma, Inc. is a clinical-stage biotechnology company focused on the discovery, development, and manufacturing of innovative therapeutic products. Its primary objective is to create protein-based treatments for challenging conditions like cancer and autoimmune disorders. The company achieves this through its proprietary XpressCF+ platform, a unique technology that integrates cell-free protein synthesis with precise, site-specific drug conjugation. Currently, Sutro's pipeline features two lead antibody-drug conjugate (ADC) candidates, both undergoing Phase 1 clinical evaluation. STRO-001 targets the CD74 protein, designed for individuals with multiple myeloma and non-Hodgkin lymphoma. The second candidate, STRO-002, is engineered to bind to folate receptor-alpha, intended for the treatment of ovarian and endometrial cancers. Strategic alliances are also a key part of its strategy, including collaborations and licensing agreements. A partnership with Merck aims to advance research programs involving cytokine derivatives for both oncological and autoimmune applications. Additionally, an agreement with Celgene Corporation focuses on identifying and developing bispecific antibodies and/or ADCs specifically within the immuno-oncology domain. Founded in 2003, the company initially operated under the name Fundamental Applied Biology, Inc. Its corporate headquarters are located in South San Francisco, California.

Market cap$159M
Employees133
Sutro Biopharma, Inc. competitors & alternatives →

Get Surf Bio, Inc.'s news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Something wrong or missing about Surf Bio, Inc.? Suggest a correction · Work at Surf Bio, Inc.? Claim this profile

Is this your company? Add the Xcout Intel badge to your website

Free, for any company on Xcout Intel. It links visitors to this profile.

Surf Bio, Inc. on Xcout Intel

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Surf Bio, Inc. — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Surf Bio, Inc. in Xcout Intel

  • 2 named people with titles, LinkedIn and board committees
  • 1 funding round with the investors in each, and who they co-invest with
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →